- Home
- BOWL vs NVAX Comparison
BOWL vs NVAX Comparison
Compare BOWL & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWL
- NVAX
- Stock Information
- Founded
- BOWL 1900
- NVAX 1987
- Country
- BOWL United States
- NVAX United States
- Employees
- BOWL N/A
- NVAX N/A
- Industry
- BOWL Services-Misc. Amusement & Recreation
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOWL Consumer Discretionary
- NVAX Health Care
- Exchange
- BOWL Nasdaq
- NVAX Nasdaq
- Market Cap
- BOWL 1.6B
- NVAX 2.0B
- IPO Year
- BOWL N/A
- NVAX 1995
- Fundamental
- Price
- BOWL $10.82
- NVAX $9.76
- Analyst Decision
- BOWL Strong Buy
- NVAX Buy
- Analyst Count
- BOWL 9
- NVAX 6
- Target Price
- BOWL $16.00
- NVAX $17.83
- AVG Volume (30 Days)
- BOWL 366.9K
- NVAX 7.2M
- Earning Date
- BOWL 11-04-2024
- NVAX 11-07-2024
- Dividend Yield
- BOWL 1.91%
- NVAX N/A
- EPS Growth
- BOWL N/A
- NVAX N/A
- EPS
- BOWL N/A
- NVAX N/A
- Revenue
- BOWL $1,154,614,000.00
- NVAX $987,667,000.00
- Revenue This Year
- BOWL $9.73
- NVAX N/A
- Revenue Next Year
- BOWL $7.42
- NVAX N/A
- P/E Ratio
- BOWL N/A
- NVAX N/A
- Revenue Growth
- BOWL 9.05
- NVAX N/A
- 52 Week Low
- BOWL $8.85
- NVAX $3.53
- 52 Week High
- BOWL $15.47
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- BOWL 42.52
- NVAX 36.20
- Support Level
- BOWL $11.15
- NVAX $9.52
- Resistance Level
- BOWL $11.79
- NVAX $10.63
- Average True Range (ATR)
- BOWL 0.43
- NVAX 0.57
- MACD
- BOWL -0.09
- NVAX -0.12
- Stochastic Oscillator
- BOWL 3.99
- NVAX 9.97
About BOWL Bowlero Corp.
Bowlero Corp is a operator of bowling entertainment centers. It operate traditional bowling centers and more upscale entertainment concepts with lounge seating, arcades, enhanced food and beverage offerings, and more robust customer service for individuals and group events, as well as hosting and overseeing professional and non-professional bowling tournaments and related broadcasting.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.